Alyeska Investment Group’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-13,349
Closed -$529K 499
2024
Q4
$529K Sell
13,349
-1,213,691
-99% -$54.7M ﹤0.01% 515
2024
Q3
$77.8M Buy
1,227,040
+441,535
+56% +$31.9M 0.4% 84
2024
Q2
$53.1M Buy
785,505
+254,761
+48% +$17.8M 0.3% 114
2024
Q1
$42M Buy
530,744
+38,517
+8% +$3.15M 0.26% 133
2023
Q4
$38.3M Buy
+492,227
New +$36.4M 0.25% 125
2022
Q4
Sell
-293,653
Closed -$23M 404
2022
Q3
$23M Buy
293,653
+68,792
+31% +$5.5M 0.27% 125
2022
Q2
$15.2M Sell
224,861
-213,883
-49% -$14.9M 0.17% 169
2022
Q1
$28.8M Buy
+438,744
New +$25.5M 0.32% 109
2021
Q3
Sell
-912,068
Closed -$57.2M 667
2021
Q2
$57.2M Buy
+912,068
New +$57.2M 0.66% 26
2020
Q4
Sell
-93,841
Closed -$2.77M 498
2020
Q3
$2.77M Buy
+93,841
New +$2.72M 0.04% 314
2015
Q3
Sell
-134,546
Closed -$10.5M 458
2015
Q2
$10.5M Buy
+134,546
New +$9.68M 0.12% 219
2013
Q4
Sell
-28,954
Closed -$1.14M 298
2013
Q3
$1.14M Sell
28,954
-121,046
-81% -$4.49M 0.05% 253
2013
Q2
$4.96M Buy
+150,000
New +$4.87M 0.24% 127

Other funds holding ACHC

Alyeska Investment Group's ACHC Position: Q1 2025 in Review

Alyeska Investment Group sold out of Acadia Healthcare (ACHC) in Q1 2025, closing a stake of 13,349 shares — an estimated $529K sold.

Alyeska Investment Group first reported a position in ACHC in Q2 2013 and held it in 13 quarters. The position peaked at $77.8M in Q3 2024. 292 funds tracked by Wall St. Rank hold ACHC as of Q1 2025.

  • Alyeska Investment Group reported no remaining Acadia Healthcare position as of Q1 2025 after selling out during the quarter.
  • Alyeska Investment Group sold 13,349 Acadia Healthcare shares in Q1 2025, an estimated $529K.
  • Alyeska Investment Group first reported a position in Acadia Healthcare in Q2 2013 and held it in 13 quarters.
  • Alyeska Investment Group's Acadia Healthcare position peaked at $77.8M in Q3 2024.
  • 292 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2025.

Based on Alyeska Investment Group's 13F filing for Q1 2025, filed 15 May 2025.